[1] DEGIRMENCI Y,ANGELOPOULOU E,GEORGAKOPOULOU V E,et al.Cognitive impairment in Parkinson's disease:An updated overview focusing on emerging pharmaceutical treatment approaches[J].Medicina(Kaunas),2023,59(10):1756. [2] BEN-SHLOMO Y,DARWEESH S,LLIBRE-GUERRA J,et al.The epidemiology of Parkinson's disease[J].Lancet,2024,403(10423):283-292. [3] BRANDAO P,MUNHOZ R P,GRIPPE T C,et al.Cognitive impairment in Parkinson's disease:A clinical and pathophysiological overview[J].J Neurol Sci,2020(419):117177. [4] ZHOU Z,YAN Y,GU H,et al.Dopamine in the prefrontal cortex plays multiple roles in the executive function of patients with Parkinson's disease[J].Neural Regen Res,2024,19(8):1759-1767. [5] PEDERSEN K F,LARSEN J P,TYSNES O B,et al.Natural course of mild cognitive impairment in Parkinson disease:A 5-year population-based study[J].Neurology,2017,88(8):767-774. [6] BORGNIS F,BAGLIO F,PEDROLI E,et al.A psychometric tool for evaluating executive functions in Parkinson's disease[J].J Clin Med,2022,11(5):1153. [7] PELICIONI P,MENANT J C,HENDERSON E J,et al.Mild and marked executive dysfunction and falls in people with Parkinson's disease[J].Braz J Phys Ther,2021,25(4):437-443. [8] HANNAWI Y.Cerebral small vessel disease:A review of the pathophysiological mechanisms[J].Transl Stroke Res,2024,15(6):1050-1069. [9] STAALS J,MAKIN S D,DOUBAL F N,et al.Stroke subtype,vascular risk factors,and total MRI brain small-vessel disease burden[J].Neurology,2014,83(14):1228-1234. [10] CHEN H,WAN H,ZHANG M,et al.Cerebral small vessel disease may worsen motor function,cognition,and mood in Parkinson's disease[J].Parkinsonism Relat Disord,2021(83):86-92. [11] ZHU R,LI Y,CHEN L,et al.Total burden of cerebral small vessel disease on MRI may predict cognitive impairment in Parkinson's disease[J].J Clin Med,2022,11(18):5381. [12] SHEN Y,DONG Z,ZHONG J,et al.Effect of cerebral small vessel disease on cognitive impairment in Parkinson's disease[J].Acta neurologica Belgica,2022,123(2):487-495. [13] LINORTNER P,MCDANIEL C,SHAHID M,et al.White matter hyperintensities related to Parkinson's disease executive function[J].Mov Disord Clin Pract,2020,7(6):629-638. [14] UITERWIJK R,van OOSTENBRUGGE R J,HUIJTS M,et al.Total cerebral small vessel disease MRI score is associated with cognitive decline in executive function in patients with hypertension[J].Front Aging Neurosci,2016(8):301. [15] POSTUMA R B,BERG D,STERN M,et al.MDS clinical diagnostic criteria for Parkinson's disease[J].Mov Disord,2015,30(12):1591-1601. [16] GOETZ C G,TILLEY B C,SHAFTMAN S R,et al.Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale(MDS-UPDRS):Scale presentation and clinimetric testing results[J].Mov Disord,2008,23(15):2129-2170. [17] LITVAN I,GOLDMAN J G,TROSTER A I,et al.Diagnostic criteria for mild cognitive impairment in Parkinson's disease:Movement Disorder Society Task Force guidelines[J].Mov Disord,2012,27(3):349-356. [18] 陈玮琪,徐佳洁,陆瑶,等.中国脑小血管病的神经影像学诊断标准及名词标准化定义:来自中国卒中学会的专家共识[J].中国卒中杂志,2024,19(4):376-404. [19] ÇEKOK F K,KAHRAMAN T,GENÇ A,et al.Association between executive and physical functions in people with Parkinson's disease[J].Somatosens Mot Res,2024,41(3):142-148. [20] GIEHL K,TAHMASIAN M,EICKHOFF S B,et al.Imaging executive functions in Parkinson's disease:An activation likelihood estimation meta-analysis[J].Parkinsonism Relat Disord,2019(63):137-142. [21] 邓文宁. 帕金森病执行功能障碍的磁共振波谱研究[D].广州:南方医科大学,2020. [22] POELS M M,IKRAM M A,VAN DER LUGT A,et al.Cerebral microbleeds are associated with worse cognitive function:The Rotterdam Scan Study[J].Neurology,2012,78(5):326-333. [23] LIU L,TU L,SHEN Q,et al.Meta-analysis of the relationship between the number and location of perivascular spaces in the brain and cognitive function[J].Neurol Sci,2024,45(8):3743-3755. |